보고서 요약(국문)

개요
글로벌 단백질 결정화 시장은 2022년 XX백만 달러에 도달했으며, 2023년부터 2030년까지 연평균 성장률(CAGR) XX%로 성장하여 2030년에는 XX백만 달러에 이를 것으로 예상됩니다.
단백질 결정은 다양한 특성과 뛰어난 맞춤화 가능성을 지닌 조직화된 분자 구조입니다. 세포 내 구성 요소로부터 자가 조립되는 특성 덕분에 환경 영향이 적고 제조 비용이 크게 절감됩니다.
단백질 결정은 다양한 기능성 분자를 수용할 수 있는 능력으로 인해 촉매로서의 가능성을 보여주지만, 현재 사용 가능한 방법으로는 단순 단백질과 미세 분자만 결정에 결합시킬 수 있습니다. 따라서 효소 고정화를 위해 단백질 결정을 최대한 활용하려면 천연 효소와 인공 기능성 분자를 모두 생산하는 방법을 개발해야 합니다.
생물약품 및 신약에 대한 수요 증가로 인해 단백질 결정화에 대한 필요성이 더욱 커지고 있습니다. 단백질 결정화는 표적 단백질 구조에 대한 이해를 높이고 신약 개발을 촉진하기 때문입니다. 구조 생물학 연구는 단백질 결정화에 크게 의존합니다. 단백질 결정화 관련 도구 및 서비스에 대한 수요는 이 분야의 발전으로 인해 증가해 왔습니다.
시장 동향: 동인
주요 기업
주요 기업들이 시장을 주도하고 있습니다. 예를 들어, 2020년 8월 미국 국립보건원(NIH)은 아칸소 의과대학(UAMS)에 1,060만 달러의 연구비를 지원했습니다.
2021년 10월, 인공지능(AI)과 딥러닝을 활용하여 단백질의 치료 잠재력을 확장하는 신약 및 표적 발굴 기업인 앱사이(Absci Corporation)와 혁신적인 신약을 저렴한 가격으로 환자에게 제공하기 위해 협력한 새로운 유형의 제약 회사인 EQRx가 발표를 진행했습니다.
2023년 7월, 도쿄 공업대학 연구진은 세포 내 엔지니어링이 흥미로운 촉매 기능을 가진 기능성 단백질 결정을 생성하는 강력한 방법이 될 수 있음을 입증했습니다. 연구진은 유전적으로 조작된 박테리아를 친환경적인 합성 플랫폼으로 사용하여 합성 광합성을 위한 하이브리드 고체 촉매를 개발했습니다. 이러한 촉매는 뛰어난 활성, 안정성 및 내구성을 보여주며, 제안된 새로운 전략의 잠재적 이점을 강조합니다.
높은 비용
단백질 결정화는 비용이 많이 들고 시간이 오래 걸리기 때문에 모든 기업이나 연구자가 이를 광범위하게 사용하지는 않습니다. 단백질 결정화 과정의 복잡하고 기술적으로 까다로운 특성으로 인해 고품질 결정을 얻기가 어려울 수 있습니다. 극저온 전자 현미경(cryo-EM)과 같은 구조 생물학의 대안적인 방법들이 점점 더 인기를 얻고 있으며, 기존의 단백질 결정화 기술에 위협이 될 수 있습니다.
세그먼트 분석
글로벌 단백질 결정화 시장은 제품 유형, 기술, 최종 사용자 및 지역별로 세분화됩니다.
기기 부문은 시장 점유율의 약 45.7%를 차지했습니다.
단백질 결정화 기기는 고품질 단백질 결정을 생성하는 데 사용되는 특수 도구 및 장비입니다. 이러한 도구는 과학 연구, 의약품 개발 및 구조 생물학 분야에 필수적입니다. 이러한 기기는 결정화의 특정 조작에 유연하고 유용하도록 설계되었습니다.

Creative Biostructure는 고객에게 최고 수준의 결정 성장, 처리 및 시딩 도구를 제공합니다. 과학 연구 활동을 위한 초소형 정밀 장비 세트는 거대 분자와 소분자 모두를 포함하는 결정화 연구에 적합합니다. 유지 관리가 간편하여 사용자는 나중에 다시 사용할 수 있습니다. 또한 정확성, 속도 및 정밀도를 자랑하는 Crystal Phoenix는 최고의 단백질 결정학 분주기입니다. 이는 앉은방울(sitting drop), 매달린방울(hanging drop) 및 마이크로배치(microbatch) 반응에 이상적인 도구입니다.
지역 분석
북미는 시장 점유율의 약 43.6%를 차지했습니다.
북미는 세계 단백질 결정화 시장에서 지배적인 위치를 차지해 왔습니다. 30년 이상 동안 미국의 바이오 제약 부문이 신약 개발을 주도해 왔으며, PhRMA 회원사들은 이러한 노력의 최전선에 서 있습니다. 2020년 미국 바이오제약 산업 전체의 연구 개발(R&D) 지출액은 약 1,220억 달러에 달하는 것으로 추산됩니다.
미국의 생물의학 연구는 지속적인 연방 정부의 재정 지원과 적극적인 캠페인 덕분에 세계적인 수준에 이르렀습니다. 바이오제약 산업은 차세대 과학자, 엔지니어, 기술 전문가를 육성하고 동기를 부여하기 위해 막대한 투자를 지속해 왔으며, 이러한 노력 덕분에 미국의 STEM 교육 시스템과 다양한 인재 양성 시스템이 향상되었습니다.
텍사스에는 포춘 500대 기업인 McKesson, Tenet Healthcare, Kimberly-Clark을 포함하여 6,000개 이상의 바이오 기술 및 생명 과학 기업이 자리 잡고 있습니다. Johnson & Johnson(J&J), Merck, Novartis, Abbott, Allergan, Lonza, Galderma 등도 텍사스 주에서 주요 사업장을 운영하고 있습니다. 또한 텍사스에는 미국 100대 의과대학 중 6곳이 있으며, 연간 66억 달러의 R&D 비용이 지출되고 있습니다.

특정 지역 내 산업 및 클러스터의 분포와 위치는 해당 지역 사회가 제공하는 부동산, 인재 및 재정적 인센티브에 따라 결정됩니다. 이러한 집중 지역은 확산되고 있으며, 특히 미네소타, 텍사스, 위스콘신에서는 더욱 성장할 여지가 있습니다.
COVID-19 영향 분석
2019년 말 발생한 COVID-19 팬데믹은 전 세계 산업, 특히 단백질 결정화 시장에 전례 없는 어려움을 초래했습니다. 봉쇄 조치와 사회적 거리두기로 인해 수많은 연구 기관과 실험실이 일시적으로 문을 닫거나 운영 능력이 저하되었습니다. 그 결과, 새로운 연구 프로젝트와 진행 중인 단백질 결정화 연구 모두 중단되었습니다.
여러 분야에서 팬데믹의 경제적 영향은 연구 자금에 영향을 미쳤습니다. 연구 그룹은 재정적 제약으로 인해 단백질 결정화 관련 서비스, 장비 및 연구에 대한 투자를 늘릴 수 없었을 수 있습니다.

제품 유형별
• 기기
o 액체 처리 기기
o 결정 이미징 기기
• 소모품
o 시약 및 키트/스크린
o 마이크로 플레이트
o 기타
• 소프트웨어 및 서비스
기술별
• X선 결정학
• 극저온 전자 현미경
• NMR 분광법
• 기타
최종 사용자별
• 제약 및 생명공학 회사
• 학술 및 연구 기관
• 기타
지역별
• 북미
o 미국
o 캐나다
o 멕시코
• 유럽
o 독일
o 영국
o 프랑스
o 이탈리아
o 스페인
o 기타 유럽
• 남미
o 브라질
o 아르헨티나
o 기타 남미
• 아시아 태평양
o 중국
o 인도
o 일본
o 호주
o 기타 아시아 태평양
• 중동 및 아프리카
경쟁 환경
주요 글로벌 시장 참여 기업으로는 METTLER TOLEDO, Corning Incorporated, Greiner Bio-One International 등이 있습니다. GmbH, HAMPTON RESEARCH CORP, Jena Bioscience GmbH, Bruker, Creative Proteomics, Molecular Dimensions 등이 있습니다.
주요 동향
• 2023년 1월, 세계적인 생명과학 투자사인 Novo Holdings는 임상 단백질체학 응용 분야 확장을 위해 단백질체학 기술 기업인 Evosep에 4천만 달러를 투자했습니다. Evosep은 이 자금을 표준화된 액체 크로마토그래피 플랫폼을 기반으로 하는 단백질체학 응용 분야 확장에 사용할 예정입니다.
보고서 구매 이유

• 제품 유형, 기술, 최종 사용자 및 지역별 글로벌 단백질 결정화 시장 세분화를 시각화하고 주요 상업 자산 및 기업을 파악하기 위해

• 트렌드 분석 및 공동 개발을 통해 사업 기회를 식별하기 위해

• 모든 세그먼트를 포함한 단백질 결정화 시장 수준의 다양한 데이터가 담긴 Excel 데이터 시트 제공

• 심층적인 질적 인터뷰와 연구를 바탕으로 한 종합적인 분석이 담긴 PDF 보고서 제공

• 주요 기업의 핵심 제품을 모두 포함하는 제품 맵핑 Excel 파일 제공 글로벌 단백질 결정화 시장 보고서는 약 61개의 표, 57개의 그림, 그리고 186페이지 분량으로 구성됩니다.
주요 독자층 (2023년 기준)
• 제조업체/구매자
• 산업 투자자/투자은행가
• 연구 전문가
• 신흥 기업

보고서 요약(영어 원문)

Overview
The Global Protein Crystallization Market reached US$ XX million in 2022 and is expected to reach US$ XX million by 2030, growing with a CAGR of XX% during the forecast period 2023-2030.
Protein crystals are organized molecular structures with a wide range of characteristics and great customizability. Their ability to self-assemble from components contained in cells lowers their environmental effect and drastically lowers the cost of manufacturing.
While protein crystals show promise as catalysts due to their ability to host a wide range of functional molecules, the methods now available only allow simple proteins and tiny molecules to connect to the crystals. Therefore, in order to fully utilize protein crystals for enzyme immobilization, methods for producing both natural enzymes and artificial functional molecules must be discovered.
The increasing need for biopharmaceuticals and novel medications has led to a greater need for protein crystallization, as it facilitates the knowledge of target protein structures and enhances drug development. Studies in structural biology depend on the crystallization of proteins. The need for tools and services related to protein crystallization has grown as a result of developments in this field.
Market Dynamics: Drivers
The Active Major Players
The active major players are driving the market. For instance, in August 2020, the National Institutes of Health (NIH) awarded the University of Arkansas for Medical Sciences (UAMS) a $10.6 million grant.
In October 2021, Absci Corporation, a drug and target discovery company that uses artificial intelligence (AI) and deep learning to extend the therapeutic potential of proteins, and EQRx, a new kind of pharmaceutical company dedicated collaborated to creating and providing significant new medicines to patients at drastically reduced prices.
In July 2023, Tokyo Tech researchers demonstrated that in-cell engineering can be a potent method for creating functional protein crystals with intriguing catalytic capabilities. The scientists created hybrid solid catalysts for synthetic photosynthesis using genetically engineered bacteria as an eco-friendly synthesis platform. These catalysts demonstrate great activity, stability, and durability, underscoring the potential benefits of the novel strategy that has been suggested.
High cost
Since protein crystallization can be costly and time-consuming, not all companies or researchers will use it substantially. It can be difficult to obtain high-quality crystals due to the intricate and technically demanding nature of the protein crystallization process. Alternative methods of structural biology, such as cryo-electron microscopy (cryo-EM), are becoming more and more popular and could pose a threat to conventional protein crystallization techniques.
Segment Analysis
The global protein crystallization market is segmented based on product type, technology, end-user and region.
The instruments segment accounted for approximately 45.7% of the market share
Instruments for protein crystallization are specialized tools and equipment used to help generate high-quality protein crystals. These tools are essential for applications in scientific research, medication development, and structural biology. These instruments are intended to be both flexible and helpful for particular manipulations of crystallization.
Creative Biostructure provides the most qualified crystal growing, handling, and seeding tools for customers. The tiniest precision devices for scientific research activity are toolsets. These instruments are proportionately appropriate for crystallization investigations involving both macromolecules and small molecules. They are simple to maintain so users can use them again later. In addition, with its accuracy, speed, and precision, the Crystal Phoenix is the best protein crystallography dispenser available. It is the ideal tool for sitting drop, hanging drop, and microbatch reactions.
Geographical Analysis
North America accounted for approximately 43.6% of the market share
North America has been a dominant force in the global protein crystallization market. The discovery of novel medications has been led by the biopharmaceutical sector in the United States for over three decades, and PhRMA member businesses remain at the forefront of this effort. An estimated $122 billion was spent on R&D by the whole US biopharmaceutical industry in 2020.
In large part due to continuous federal financing and fervent campaigning in the US, biomedical research has reached this point in the world. The nation's STEM education system and varied talent pipeline have been improved by the biopharmaceutical industry's enormous and ongoing commitment to motivating and nurturing the next generation of scientists, engineers, and technology professionals.
More than 6,000 biotech and life sciences companies call Texas home, including the Fortune 500 corporations McKesson, Tenet Healthcare, and Kimberly-Clark. The following companies have major operations in the state: Johnson & Johnson (J&J), Merck, Novartis, Abbott, Allergan, Lonza, and Galderma. In addition, Texas is home to six of the top 100 medical schools in the US and $6.6 billion in R&D spending annually.
The distribution and positioning of industries and clusters within an area are determined by the real estate, talent, and financial incentives provided by the local community. These areas of concentration are spreading and, crucially, have room to grow further in Minnesota, Texas, and Wisconsin.
COVID-19 Impact Analysis
The outbreak of the COVID-19 pandemic in late 2019 created unprecedented challenges for industries worldwide, including the global protein crystallization market. Lockdowns and social distancing tactics resulted in the temporary closure of numerous research organizations and laboratories, or in their capacity being decreased. As a result, both new research projects and ongoing protein crystallization investigations were put on hold.
In several areas, the pandemic's economic effects had an impact on research funding. Research groups may not have been able to invest as much in services, equipment, and investigations related to protein crystallization due to financial constraints.
By Product Type
• Instruments
o Liquid Handling Instruments
o Crystal Imaging Instruments
• Consumables
o Reagents & Kits/Screens
o Micro Plates
o Others
• Software & Services
By Technology
• X-ray Crystallography
• Cryo-electron Microscopy
• NMR Spectroscopy
• Others
By End-User
• Pharmaceutical and biotechnology companies
• Academic and Research Institutes
• Others
By Region
• North America
o U.S.
o Canada
o Mexico
• Europe
o Germany
o UK
o France
o Italy
o Spain
o Rest of Europe
• South America
o Brazil
o Argentina
o Rest of South America
• Asia-Pacific
o China
o India
o Japan
o Australia
o Rest of Asia-Pacific
• Middle East and Africa
Competitive Landscape
The major global players in the market include METTLER TOLEDO, Corning Incorporated, Greiner Bio-One International GmbH, HAMPTON RESEARCH CORP, Jena Bioscience GmbH, Bruker, Creative Proteomics, Molecular Dimensions among others.
Key Developments
• In January 2023, Novo Holdings, a worldwide life science investor invested $40 million in proteomics Technology company Evosep to expand clinical proteomics applications. The money will be used by Evosep to expand the proteomics applications made possible by its platform of standardized liquid chromatography.
Why Purchase the Report?
• To visualize the global protein crystallization market segmentation based on product type, technology, end-user and region as well as understand key commercial assets and players.
• Identify commercial opportunities by analyzing trends and co-development.
• Excel data sheet with numerous data points of protein crystallization market-level with all segments.
• PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
• Product mapping available as excel consisting of key products of all the major players.
The global protein crystallization market report would provide approximately 61 tables, 57 figures, and 186 Pages.
Target Audience 2023
• Manufacturers/ Buyers
• Industry Investors/Investment Bankers
• Research Professionals
• Emerging Companies

상세 목차

1. Methodology and Scope
1.1. Research Methodology
1.2. Research Objective and Scope of the Report
2. Definition and Overview
3. Executive Summary
3.1. Snippet by Product Type
3.2. Snippet by Technology
3.3. Snippet by End-User
3.4. Snippet by Region
4. Dynamics
4.1. Impacting Factors
4.1.1. Drivers
4.1.1.1. The Active Major Players
4.1.1.2. XX
4.1.2. Restraints
4.1.2.1. High Cost
4.1.2.2. XX
4.1.3. Opportunity
4.1.4. Impact Analysis
5. Industry Analysis
5.1. Porter's Five Force Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis
5.5. SWOT Analysis
5.6. Patent Analysis
5.7. DMI Opinion
6. COVID-19 Analysis
6.1. Analysis of COVID-19
6.1.1. Scenario Before COVID
6.1.2. Scenario During COVID
6.1.3. Scenario Post COVID
6.2. Pricing Dynamics Amid COVID-19
6.3. Demand-Supply Spectrum
6.4. Government Initiatives Related to the Market During Pandemic
6.5. Manufacturers Strategic Initiatives
6.6. Conclusion
7. By Product Type
7.1. Introduction
7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
7.1.2. Market Attractiveness Index, By Product Type
7.2. Instruments*
7.2.1. Introduction
7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Liquid Handling Instruments
7.4. Crystal Imaging Instruments
7.5. Consumables
7.6. Reagents & Kits/Screens
7.7. Micro Plates
7.8. Others
7.9. Software & Services
8. By Technology
8.1. Introduction
8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
8.1.2. Market Attractiveness Index, By Technology
8.2. X-ray Crystallography*
8.2.1. Introduction
8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. X-ray Crystallography
8.4. Cryo-electron Microscopy
8.5. NMR Spectroscopy
8.6. Others
9. By End-User
9.1. Introduction
9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
9.1.2. Market Attractiveness Index, By End-User
9.2. Pharmaceutical and Bio Technology Companies*
9.2.1. Introduction
9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
9.3. Academic And Research Institutes
10. By Region
10.1. Introduction
10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
10.1.2. Market Attractiveness Index, By Region
10.2. North America
10.2.1. Introduction
10.2.2. Key Region-Specific Dynamics
10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
10.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
10.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
10.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
10.2.6.1. U.S.
10.2.6.2. Canada
10.2.6.3. Mexico
10.3. Europe
10.3.1. Introduction
10.3.2. Key Region-Specific Dynamics
10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
10.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
10.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
10.3.6.1. Germany
10.3.6.2. UK
10.3.6.3. France
10.3.6.4. Italy
10.3.6.5. Spain
10.3.6.6. Rest of Europe
10.4. South America
10.4.1. Introduction
10.4.2. Key Region-Specific Dynamics
10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
10.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
10.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
10.4.6.1. Brazil
10.4.6.2. Argentina
10.4.6.3. Rest of South America
10.5. Asia-Pacific
10.5.1. Introduction
10.5.2. Key Region-Specific Dynamics
10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
10.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
10.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
10.5.6.1. China
10.5.6.2. India
10.5.6.3. Japan
10.5.6.4. Australia
10.5.6.5. Rest of Asia-Pacific
10.6. Middle East and Africa
10.6.1. Introduction
10.6.2. Key Region-Specific Dynamics
10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
10.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
10.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
11. Competitive Landscape
11.1. Competitive Scenario
11.2. Market Positioning/Share Analysis
11.3. Mergers and Acquisitions Analysis
12. Company Profiles
12.1. Rigaku Corporation*
12.1.1. Company Overview
12.1.2. Product Portfolio and Description
12.1.3. Financial Overview
12.1.4. Key Developments
12.2. FORMULATRIX
12.3. METTLER TOLEDO
12.4. Corning Incorporated
12.5. Greiner Bio-One International GmbH
12.6. HAMPTON RESEARCH CORP
12.7. Jena Bioscience GmbH
12.8. Bruker
12.9. Creative Proteomics
12.10. Molecular Dimensions
LIST NOT EXHAUSTIVE
13. Appendix
13.1. About Us and Services
13.2. Contact Us

언급된 주요 기업들

Rigaku Corporation, 4.	Key Developments, FORMULATRIX, METTLER TOLEDO, Corning Incorporated, Greiner Bio-One International GmbH, HAMPTON RESEARCH CORP, Jena Bioscience GmbH, Bruker, Creative Proteomics, Molecular Dimensions

표 목록 (Tables)

List of Tables

Table 1 Global Protein Crystallization Market Value, By Product Type, 2023, 2027 & 2031 (US$ Million)

Table 2 Global Protein Crystallization Market Value, By Technology, 2023, 2027 & 2031 (US$ Million)

Table 3 Global Protein Crystallization Market Value, By End-User, 2023, 2027 & 2031 (US$ Million)

Table 4 Global Protein Crystallization Market Value, By Region, 2023, 2027 & 2031 (US$ Million)

Table 5 Global Protein Crystallization Market Value, By Product Type, 2023, 2027 & 2031 (US$ Million)

Table 6 Global Protein Crystallization Market Value, By Product Type, 2022-2031 (US$ Million)

Table 7 Global Protein Crystallization Market Value, By Technology, 2023, 2027 & 2031 (US$ Million)

Table 8 Global Protein Crystallization Market Value, By Technology, 2022-2031 (US$ Million)

Table 9 Global Protein Crystallization Market Value, By End-User, 2023, 2027 & 2031 (US$ Million)

Table 10 Global Protein Crystallization Market Value, By End-User, 2022-2031 (US$ Million)

Table 11 Global Protein Crystallization Market Value, By Region, 2023, 2027 & 2031 (US$ Million)

Table 12 Global Protein Crystallization Market Value, By Region, 2022-2031 (US$ Million)

Table 13 North America Protein Crystallization Market Value, By Product Type, 2022-2031 (US$ Million)

Table 14 North America Protein Crystallization Market Value, By Technology, 2022-2031 (US$ Million)

Table 15 North America Protein Crystallization Market Value, By End-User, 2022-2031 (US$ Million)

Table 16 North America Protein Crystallization Market Value, By Country, 2022-2031 (US$ Million)

Table 17 South America Protein Crystallization Market Value, By Product Type, 2022-2031 (US$ Million)

Table 18 South America Protein Crystallization Market Value, By Technology, 2022-2031 (US$ Million)

Table 19 South America Protein Crystallization Market Value, By End-User, 2022-2031 (US$ Million)

Table 20 South America Protein Crystallization Market Value, By Country, 2022-2031 (US$ Million)

Table 21 Europe Protein Crystallization Market Value, By Product Type, 2022-2031 (US$ Million)

Table 22 Europe Protein Crystallization Market Value, By Technology, 2022-2031 (US$ Million)

Table 23 Europe Protein Crystallization Market Value, By End-User, 2022-2031 (US$ Million)

Table 24 Europe Protein Crystallization Market Value, By Country, 2022-2031 (US$ Million)

Table 25 Asia-Pacific Protein Crystallization Market Value, By Product Type, 2022-2031 (US$ Million)

Table 26 Asia-Pacific Protein Crystallization Market Value, By Technology, 2022-2031 (US$ Million)

Table 27 Asia-Pacific Protein Crystallization Market Value, By End-User, 2022-2031 (US$ Million)

Table 28 Asia-Pacific Protein Crystallization Market Value, By Country, 2022-2031 (US$ Million)

Table 29 Middle East & Africa Protein Crystallization Market Value, By Product Type, 2022-2031 (US$ Million)

Table 30 Middle East & Africa Protein Crystallization Market Value, By Technology, 2022-2031 (US$ Million)

Table 31 Middle East & Africa Protein Crystallization Market Value, By End-User, 2022-2031 (US$ Million)

Table 32 Rigaku Corporation: Overview

Table 33 Rigaku Corporation: Product Portfolio

Table 34 Rigaku Corporation: Key Developments

Table 35 FORMULATRIX: Overview

Table 36 FORMULATRIX: Product Portfolio

Table 37 FORMULATRIX: Key Developments

Table 38 METTLER TOLEDO: Overview

Table 39 METTLER TOLEDO: Product Portfolio

Table 40 METTLER TOLEDO: Key Developments

Table 41 Corning Incorporated: Overview

Table 42 Corning Incorporated: Product Portfolio

Table 43 Corning Incorporated: Key Developments

Table 44 Greiner Bio-One International GmbH: Overview

Table 45 Greiner Bio-One International GmbH: Product Portfolio

Table 46 Greiner Bio-One International GmbH: Key Developments

Table 47 HAMPTON RESEARCH CORP: Overview

Table 48 HAMPTON RESEARCH CORP: Product Portfolio

Table 49 HAMPTON RESEARCH CORP: Key Developments

Table 50 Jena Bioscience GmbH: Overview

Table 51 Jena Bioscience GmbH: Product Portfolio

Table 52 Jena Bioscience GmbH: Key Developments

Table 53 Bruker: Overview

Table 54 Bruker: Product Portfolio

Table 55 Bruker: Key Developments

Table 56 Creative Proteomics: Overview

Table 57 Creative Proteomics: Product Portfolio

Table 58 Creative Proteomics: Key Developments

Table 59 Molecular Dimensions: Overview

Table 60 Molecular Dimensions: Product Portfolio

Table 61 Molecular Dimensions: Key Developments

그림 목록 (Figures)

List of Figures

Figure 1 Global Protein Crystallization Market Value, 2022-2031 (US$ Million)

Figure 2 Global Protein Crystallization Market Share, By Product Type, 2022 & 2031 (%)

Figure 3 Global Protein Crystallization Market Share, By Technology, 2022 & 2031 (%)

Figure 4 Global Protein Crystallization Market Share, By End-User, 2022 & 2031 (%)

Figure 5 Global Protein Crystallization Market Share, By Region, 2022 & 2031 (%)

Figure 6 Global Protein Crystallization Market Y-o-Y Growth, By Product Type, 2022-2031 (%)

Figure 7 Instruments Protein Crystallization Market Value, 2022-2031 (US$ Million)

Figure 8 Consumables Protein Crystallization Market Value, 2022-2031 (US$ Million)

Figure 9 Software & Services Protein Crystallization Market Value, 2022-2031 (US$ Million)

Figure 10 Global Protein Crystallization Market Y-o-Y Growth, By Technology, 2022-2031 (%)

Figure 11 X-ray Crystallography Technology in Global Protein Crystallization Market Value, 2022-2031 (US$ Million)

Figure 12 Cryo-electron Microscopy Technology in Global Protein Crystallization Market Value, 2022-2031 (US$ Million)

Figure 13 NMR Spectroscopy Technology in Global Protein Crystallization Market Value, 2022-2031 (US$ Million)

Figure 14 Others Technology in Global Protein Crystallization Market Value, 2022-2031 (US$ Million)

Figure 15 Global Protein Crystallization Market Y-o-Y Growth, By End-User, 2022-2031 (%)

Figure 16 Pharmaceutical and Bio Technology Companies End-User in Global Protein Crystallization Market Value, 2022-2031 (US$ Million)

Figure 17 Academic And Research Institutes End-User in Global Protein Crystallization Market Value, 2022-2031 (US$ Million)

Figure 18 Global Protein Crystallization Market Y-o-Y Growth, By Region, 2022-2031 (%)

Figure 19 North America Protein Crystallization Market Value, 2022-2031 (US$ Million)

Figure 20 Asia-Pacific Protein Crystallization Market Value, 2022-2031 (US$ Million)

Figure 21 Europe Protein Crystallization Market Value, 2022-2031 (US$ Million)

Figure 22 South America Protein Crystallization Market Value, 2022-2031 (US$ Million)

Figure 23 Middle East and Africa Protein Crystallization Market Value, 2022-2031 (US$ Million)

Figure 24 North America Protein Crystallization Market Value, 2022-2031 (US$ Million)

Figure 25 North America Protein Crystallization Market Share, By Product Type, 2022 & 2031 (%)

Figure 26 North America Protein Crystallization Market Share, By Technology, 2022 & 2031 (%)

Figure 27 North America Protein Crystallization Market Share, By End-User, 2022 & 2031 (%)

Figure 28 North America Protein Crystallization Market Share, By Country, 2022 & 2031 (%)

Figure 29 South America Protein Crystallization Market Value, 2022-2031 (US$ Million)

Figure 30 South America Protein Crystallization Market Share, By Product Type, 2022 & 2031 (%)

Figure 31 South America Protein Crystallization Market Share, By Technology, 2022 & 2031 (%)

Figure 32 South America Protein Crystallization Market Share, By End-User, 2022 & 2031 (%)

Figure 33 South America Protein Crystallization Market Share, By Country, 2022 & 2031 (%)

Figure 34 Europe Protein Crystallization Market Value, 2022-2031 (US$ Million)

Figure 35 Europe Protein Crystallization Market Share, By Product Type, 2022 & 2031 (%)

Figure 36 Europe Protein Crystallization Market Share, By Technology, 2022 & 2031 (%)

Figure 37 Europe Protein Crystallization Market Share, By End-User, 2022 & 2031 (%)

Figure 38 Europe Protein Crystallization Market Share, By Country, 2022 & 2031 (%)

Figure 39 Asia-Pacific Protein Crystallization Market Value, 2022-2031 (US$ Million)

Figure 40 Asia-Pacific Protein Crystallization Market Share, By Product Type, 2022 & 2031 (%)

Figure 41 Asia-Pacific Protein Crystallization Market Share, By Technology, 2022 & 2031 (%)

Figure 42 Asia-Pacific Protein Crystallization Market Share, By End-User, 2022 & 2031 (%)

Figure 43 Asia-Pacific Protein Crystallization Market Share, By Country, 2022 & 2031 (%)

Figure 44 Middle East & Africa Protein Crystallization Market Value, 2022-2031 (US$ Million)

Figure 45 Middle East & Africa Protein Crystallization Market Share, By Product Type, 2022 & 2031 (%)

Figure 46 Middle East & Africa Protein Crystallization Market Share, By Technology, 2022 & 2031 (%)

Figure 47 Middle East & Africa Protein Crystallization Market Share, By End-User, 2022 & 2031 (%)

Figure 48 Rigaku Corporation : Financials

Figure 49 FORMULATRIX: Financials

Figure 50 METTLER TOLEDO: Financials

Figure 51 Corning Incorporated: Financials

Figure 52 Greiner Bio-One International GmbH: Financials

Figure 53 HAMPTON RESEARCH CORP: Financials

Figure 54 Jena Bioscience GmbH: Financials

Figure 55 Bruker: Financials

Figure 56 Creative Proteomics: Financials

Figure 57 Molecular Dimensions: Financials

글로벌 단백질 결정화 시장 – 2023-2030

Global Protein Crystallization Market - 2023-2030